Skip to main content
Loading...

GE Healthcare Receives FDA Clearance for First Artificial Intelligence (AI) Algorithm to Help Assess Endotracheal Tube Placement

GE Healthcare today announced it has received Food and Drug Administration (FDA) approval for an artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements.

GE Healthcare today announced it has received Food and Drug Administration (FDA) approval for an artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements. The AI solution is one of five included in GE Healthcare’s Critical Care Suite 2.0, an industry-first collection of AI algorithms embedded on a mobile x-ray device for automated measurements, case prioritization and quality control.
“We are pleased to now have the FDA’s clearance for this important solution,” Jan Makela, president and CEO of imaging at GE Healthcare, said in a statement. “The pandemic has proven what we already knew—that data, AI and connectivity are central to helping front line clinicians deliver intelligently efficient care.

Read more:
https://www.fda.gov/

Leave a Comment